glp 1 heart disease GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential GLP-1 and the cardiovascular system

Data suggest that GIP worsens insulin sensitivity through effects on cytokine production [12] in adipose tissue [13]

For instance, in January 2025, the FDA approved semaglutide (Ozempic) as a medication to reduce the risk of kidney failure, kidney disease progression, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD)

Well explore free or low-cost exercise options in your community, such as walking groups, community fitness classes, or online workout videos

What the Study Found The participants in this study all had a BMI greater than 27

As of February 28, 2024, Novo Nordisks share price had risen by over 70% in the previous year [see Figure 3], with its market cap in September briefly surpassing Denmarks annual GDP